# Use of a Fermented Dairy Beverage in Cervical Cancer Patients Undergoing Concurrent Chemoradiation Therapy

> **NCT05736315** · NA · COMPLETED · sponsor: **National Institute of Cancerología** · enrollment: 42 (actual)

## Conditions studied

- Cervical Cancer, Stage IIB

## Interventions

- **OTHER:** Placebo dairy beverage

## Key facts

- **NCT ID:** NCT05736315
- **Lead sponsor:** National Institute of Cancerología
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04-25
- **Primary completion:** 2007-06-25
- **Final completion:** 2022-03-11
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2023-02-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05736315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05736315, "Use of a Fermented Dairy Beverage in Cervical Cancer Patients Undergoing Concurrent Chemoradiation Therapy". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT05736315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*